A multicenter validation of computerized tomography models as predictors of non- optimal primary cytoreduction of advanced epithelial ovarian cancer

European Journal of Surgical Oncology

Volumn 35, Issue 10, 2009, Pages 1109-1112

  Gemer, O ^a   Gdalevich, M ^b   Ravid, M ^c   Piura, B ^c   Rabinovich, A ^c   Gasper, T ^d   Khashper, A ^d   Voldarsky, M ^a   Linov, L ^a   Ben Shachar, I ^e   Anteby, E Y ^a   Lavie, O ^d  

^a BARZILAI MEDICAL CENTER   (Israel)

^b Epidemiology Research Institute   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d CARMEL MEDICAL CENTER   (Israel)

^e HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Computerized tomography; Debulking; Ovarian cancer; Prediction

Indexed keywords

ADVANCED CANCER; ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OVARY CANCER; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PATIENT SELECTION; PREOPERATIVE CARE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; TOMOGRAPHY, X-RAY COMPUTED;

EID: 69949093454     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2009.03.002     Document Type: Article

References (24)

1. Hacker N.F., Berek J.S., Lagasse L.D., Nieberg R.K., and Elashoff R.M. Primary cytoreductive surgery for epithelial ovarian cancer. Obstet Gynecol 61 (1983) 413-420
2. Hoskins W.J., Bundy B.N., Thigpen J.T., and Omura G.A. The influence of cytoreductive surgery on recurrence-free interval and survival in small volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol 47 (1992) 159-166
3. Hoskins W.J., McGuire W.P., Brady M.F., et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 170 (1994) 974-979
4. Bristow R.E., Tomacruz R.S., Armstrong D.K., Trimble E.L., and Montz F.J. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20 (2002) 1248-1259
5. Van Der Burg M.E., and Vergote I. Gynecological Cancer Group of the EORTC. The role of interval debulking surgery in ovarian cancer. Curr Oncol Rep 5 (2003) 473-481
6. Van der Burg M.E., van Lent M., Buyse M., et al. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med 332 (1995) 629-634
7. Vergote I., De Wever I., Tjaima W., Van Gramberen M., Decloedt J., and Van Dam P. Neoadjuvant chemotherapy of primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients. Gynecol Oncol 71 (1998) 431-436
8. Nelson B.E., Rosenfield A.T., and Schwartz P.E. Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. J Clin Oncol 11 (1993) 166-172
9. Bristow R.E., Duska L.R., Lambrou N.C., et al. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer 89 (2000) 1532-1540
10. Dowdy S.C., Mullany S.A., Brandt K.R., Huppert B.J., and Cliby W.A. The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma. Cancer 101 (2004) 346-352
11. Qayyum A., Coakley F.V., Westphalen A.C., Hricak H., Okuno W.T., and Powell B. Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. Gynecol Oncol 96 (2005) 301-306
12. Axtell A.E., Lee M.H., Bristow R.E., et al. Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer. J Clin Oncol 25 4 (2007) 384-389
13. Eisenkop S.M., Friedman R.L., and Wang H.J. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol Oncol 69 (1998) 103-108
14. Schwartz P.E., Rutherford T.J., Chambers J.T., Kohorn E.L., and Thiel R.P. Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival. Gynecol Oncol 72 (1999) 93-99
15. Ansquer Y., Leblanc E., Clough K., et al. Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study. Cancer 91 (2001) 2329-2334
16. ergote I.B., De Wever I., Decloedt J., Tjalma W., Van Gramberen M., and van Dam P. Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer. Semin Oncol 27 Suppl. 7 (2000) 31-36
17. Kuhn W., Rutke S., Spathe K., et al. Neoadjuvant chemotherapy followed by tumor debulking prolongs survival in patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma. Cancer 92 (2001) 2585-2591
18. Everett E.N., French A.E., Stone R.L., et al. Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelial ovarian cancer. Am J Obstet Gynecol 195 2 (2006) 568-574
19. Memarzadeh S., Lee S.B., Berek J.S., and Farias-Eisner R. CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer. Int J Gynecol Cancer 13 (2003) 120-124
20. Gemer O., Lurian M., Gdalevich M., et al. A multicenter study of CA125 level as a predictor of non-optimal primary cytoreduction of advanced epithelial ovarian cancer. Eur J Surg Oncol 31 9 (2005) 1006-1010
21. Salani R., Axtell A., Gerardi M., Holschneider C., and Bristow R.E. Limited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian cancer. Gynecol Oncol 108 2 (2008) 271-275
22. Risum S., Høgdall C., Loft A., et al. Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography-a prospective study. Gynecol Oncol 108 2 (2008) 265-270
23. Vergote I., Marquette S., Amant F., Berteloot P., and Neven P. Port-site metastases after open laparoscopy: a study in 173 patients with advanced ovarian carcinoma. Int J Gynecol Cancer 15 5 (2005) 776-779
24. Suh-Burgmann E., and Powell C.B. Cytoreductive surgery for gynecologic malignancies - new standards of care. Surg Oncol Clin N Am 16 3 (2007) 667-682